Alzheimer's disease, β-amyloid, glutamate, N M DA receptors and memantine ― searching for the connectionsDANYSZ, Wojciech; PARSONS, Chris G.British journal of pharmacology. 2012, Vol 167, Num 2, pp 324-352, issn 0007-1188, 29 p.Article

Behavioural and cellular effects of exogenous amyloid-β peptides in rodentsCHAMBON, Caroline; WEGENER, Nico; GRAVIUS, Andreas et al.Behavioural brain research. 2011, Vol 225, Num 2, pp 623-641, issn 0166-4328, 19 p.Article

The role of group I mGlu receptors in the expression of ethanol-induced conditioned place preference and ethanol withdrawal seizures in ratsKOTLINSKA, Jolanta H; BOCHENSKI, Marcin; DANYSZ, Wojciech et al.European journal of pharmacology. 2011, Vol 670, Num 1, pp 154-161, issn 0014-2999, 8 p.Article

Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in ratsKOZELA, Ewa; DANYSZ, Wojciech; POPIK, Piotr et al.European journal of pharmacology. 2001, Vol 423, Num 1, pp 17-26, issn 0014-2999Article

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds : Further validation of the rat dyskinesia modelDEKUNDY, Andrzej; LUNDBLAD, Martin; DANYSZ, Wojciech et al.Behavioural brain research. 2007, Vol 179, Num 1, pp 76-89, issn 0166-4328, 14 p.Article

Effect of neramexane on ethanol dependence and reinforcementKOTLINSKA, Jolanta; BIALA, Grazyna; RAFALSKI, Piotr et al.European journal of pharmacology. 2004, Vol 503, Num 1-3, pp 95-98, issn 0014-2999, 4 p.Article

The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in ratBACHTELER, Daniel; ECONOMIDOU, Daina; DANYSZ, Wojciech et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 6, pp 1104-1110, issn 0893-133X, 7 p.Article

The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidenceDANYSZ, Wojciech; PARSONS, Chris G.International journal of geriatric psychiatry. 2003, Vol 18, pp S23-S32, issn 0885-6230, SUP1Conference Paper

Effects of glutamate and α2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in ratsALAM, Mesbah; DANYSZ, Wojciech; SCHMIDT, Werner Jürgen et al.Toxicology and applied pharmacology. 2009, Vol 240, Num 2, pp 198-207, issn 0041-008X, 10 p.Article

Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivoSZYDLOWSKA, Kinga; KAMINSKA, Bozena; BAUDE, Andrea et al.European journal of pharmacology. 2007, Vol 554, Num 1, pp 18-29, issn 0014-2999, 12 p.Article

Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in ratsPIETRASZEK, Małgorzata; SUKHANOV, Ilia; MACIEJAK, Piotr et al.European journal of pharmacology. 2005, Vol 514, Num 1, pp 25-34, issn 0014-2999, 10 p.Article

Comparison of the mGlu₅ receptor positive allosteric modulator ADX47273 and the mGlu_2/3 receptor agonist LY354740 in tests for antipsychotic-like activitySCHLUMBERGER, Chantal; PIETRASZEK, Małgorzata; GRAVIUS, Andreas et al.European journal of pharmacology. 2009, Vol 623, Num 1-3, pp 73-83, issn 0014-2999, 11 p.Article

Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesiaVALASTRO, Barbara; DEKUNDY, Andrzej; KROGH, Morten et al.Journal of neurochemistry. 2007, Vol 102, Num 4, pp 1395-1409, issn 0022-3042, 15 p.Article

Neuroprotective potential of group I metabotropic glutamate receptor antagonists in two ischemic modelsMAKAREWICZ, Dorota; DUSZCZYK, Malgorzata; GADAMSKI, Roman et al.Neurochemistry international. 2006, Vol 48, Num 6-7, pp 485-490, issn 0197-0186, 6 p.Conference Paper